MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer (MOZART)

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT05903092

Study Contact: studies@hoosiercancer.org; (317) 921-2050.

Abstracts/Posters/Presentations: 

• H Mamdani, S Kim, R Gentzler, M Shields, M Furqan, K Pizana, Q Abid, S Ibrahim. A phase II trial of monalizumab in combination with durvalumab (MEDI4736) plus platinum-based chemotherapy for first-line treatment of extensive stage small cell lung cancer (MOZART): Hoosier Cancer Research Network LUN21-530 study. Presented as a poster at 2024 ASCO. See abstract.